Masimo (MASI) Divestments (2024 - 2025)
Masimo's (MASI) quarterly Divestments came in at $287.6 million in Q3 2025, up 3740.51% year-on-year from $7.5 million in Q3 2024, and up 6788.37% quarter-over-quarter from -$4.3 million in Q2 2025.
Masimo (MASI) Divestments (2024 - 2025) Analysis & Trends
Masimo's Divestments history runs 2 years deep, the most recent figure standing at $287.6 million for Q3 2025.
- On a quarterly basis, Divestments rose 3740.51% year-over-year to $287.6 million in Q3 2025; TTM through Apr 2026 was $283.3 million, a 1331.74% increase from a year earlier, with the FY2026 full-year figure at $278.5 million, up 1158.94% from the prior year.
- Divestments rose to $287.6 million in Q3 2025 per MASI's latest filing, from -$4.3 million in the prior quarter.
- Across five years, Divestments topped out at $287.6 million in Q3 2025 and bottomed at -$8.1 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.37 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 27, 2025 | 287.60 Mn |
| Jun 28, 2025 | -4.30 Mn |
| Mar 29, 2025 | -4.80 Mn |
| Dec 28, 2024 | -5.30 Mn |
| Sep 28, 2024 | -7.90 Mn |
| Jun 29, 2024 | -5.00 Mn |
| Mar 30, 2024 | -8.10 Mn |